Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Elevated Lipoprotein(a) Linked to Long-Term Progression of Carotid Atherosclerosis

By LabMedica International staff writers
Posted on 08 Oct 2026

Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease. More...

Its relationship to long-term carotid atherosclerosis has remained unclear, particularly in East Asian populations. Since carotid plaque development and progression to stenosis reflect vascular disease burden, clarifying this relationship could improve risk assessment.

National Cerebral and Cardiovascular Center researchers in Japan evaluated Lp(a) as a blood-based marker linked to carotid atherosclerosis progression. The analysis focused on Lp(a) levels and repeated carotid ultrasound findings in participants from the Suita Study. Lp(a) concentrations were categorized as less than 15, 15–29, 30–49, and at least 50 mg/dL.

The study included 3,272 participants with no history of cardiovascular disease and no carotid plaque at baseline. Participants underwent repeated carotid ultrasound examinations every two years through June 2016. During a median follow-up of 11.5 years, 1,432 participants developed a new carotid plaque.

Compared with participants whose Lp(a) levels were below 15 mg/dL, those with Lp(a) levels of at least 50 mg/dL had a higher risk of carotid plaque development, with a multivariable-adjusted hazard ratio of 1.27. Participants in the higher Lp(a) group also showed faster annual progression of carotid intima-media thickness. Among participants who developed carotid plaques, Lp(a) levels of at least 50 mg/dL were associated with more than twice the odds of progression to at least 50% carotid stenosis.

Only about 5% of participants had Lp(a) levels of at least 50 mg/dL, but this group showed consistently higher risk across multiple stages of carotid atherosclerosis. The findings suggest that Lp(a) levels of at least 50 mg/dL may be useful for risk stratification even in East Asian populations. The findings were published in the European Journal of Preventive Cardiology on October 7, 2026.

“Our findings suggest that elevated Lp(a) is associated with the continuum of carotid atherosclerosis, from plaque initiation to luminal stenosis. Measuring Lp(a) may help identify individuals at an increased lifetime risk of atherosclerosis beyond conventional cardiovascular risk factors,” said Masayuki Teramoto.

Related Links
National Cerebral and Cardiovascular Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.